ログイン

CSF 1

CSF 1
100問 • 2年前
  • Yves Laure Pimentel
  • 通報

    問題一覧

  • 1

    produce a mechanical barrier to cushion the cushion the brain and spinal cord against trauma trauma * Supply nutrients to the nervous tissue * Remove metabolic waste

    CEREBROSPINAL FLUID (CSF)

  • 2

    not an ultrafiltrate of plasma

    CEREBROSPINAL FLUID (CSF)

  • 3

    Brain & spinal cord are lined by

    Meninges

  • 4

    3 parts of meninges

    1. DURA MATER, 2. ARACHNOID MATER, 3.PIA MATER

  • 5

    outer layer; lines the skull & vertebral canal

    DURA MATER

  • 6

    Spider web-like/ filamentous inner membrane

    ARACHNOID

  • 7

    Thin membrane lining the surfaces of brain & spinal cord

    PIA MATER

  • 8

    PRODUCTION OF CSF

    Produced in CHOROID PLEXUS of lumbar ventricles & third & fourth ventricles

  • 9

    Flows through _________(Between arachnoid & pia mater)

    SUBARACHNOID

  • 10

    Reabsorbed by the _______________into the superior sagittal sinus

    ARACHNOID VILLI/ GRANULATION

  • 11

    CSF VOLUME:

    20 ML/PER HOUR

  • 12

    Adults: CSF VOLUME

    40-170 ML/ 90-150 ML

  • 13

    CSF VOLUME Neonates:

    10-60 mL

  • 14

    Endothelial cells have ________to prevent passage of molecules: How many Daltons?

    BLOOD BRAIN BARRIER (BBB): >500 daltons

  • 15

    used to represent the control and filtration of blood components to the CSF and then to the brain

    BLOOD BRAIN BARRIER (BBB)

  • 16

    Increased WBC, proteins, and coagulation factors in CSF

    Meningitis, Multiple Sclerosis

  • 17

    Routine method for CSF collection

    LUMBAR PUNCTURE

  • 18

    Between _____ Lumbar Vertebrae:

    3RD, 4TH, 5TH

  • 19

    Lumbar Vertebrae: ADULTS

    3RD AND 4TH

  • 20

    Lumbar Vertebrae: CHILDREN

    4TH AND 5TH

  • 21

    Patientis position in lumbar puncture

    FETAL POSITION OR LATERAL DECUBITUS POSITION

  • 22

    infants w/ open fontanels

    VENTICULAR PUNCTURE

  • 23

    collected in sub-occipital region

    CISTERIAL PUNCTURE

  • 24

    "Least affected by blood bacteria as a result of the tap procedure

    TUBE 1 CHEMISTRY AND SEROLOGY

  • 25

    TUBE 2 AND PRESERVATIVE

    MICROBIOLOGY, ROOM TEMPERATURE

  • 26

    Least likely fo contain C cells introduced by the tap procedure

    HEMATOLOGY/ CELL COUNT, REF TEMPERATURE; TUBE 3

  • 27

    LAST TUBE

    MICROBIOLOGY

  • 28

    Tests are performed on a ? WITHIN?

    STAT basis: 30 MINS

  • 29

    Supernatant fluid that is left over in every section:

    CHEMISTRY/ SEROLOGY

  • 30

    IF ONLY 1 TUBE: ORDER OF COLLECTION

    MICROBIOLOGY-> HEMATOLOGY-> CHEMISTRY/SEROLOGY

  • 31

    PHYSICAL EXAMINATION OR APPEARANCE OF CSF: ¥ Color:

    COLORLESS

  • 32

    PHYSICAL EXAMINATION OR APPEARANCE OF CSF: Viscosity:

    Same w/ water

  • 33

    PHYSICAL EXAMINATION OR APPEARANCE OF CSF: CLARITY

    Crystal Clear

  • 34

    PHYSICAL EXAMINATION OR APPEARANCE OF CSF: SPECIFIC GRAVITY

    1.006-1.008

  • 35

    PHYSICAL EXAMINATION OR APPEARANCE OF CSF: pH:

    7.30-7.45

  • 36

    PHYSICAL EXAMINATION OR APPEARANCE OF CSF: Pressure:

    50-200 mmH2

  • 37

    Slightly Hazy

    200-500 WBC/UL

  • 38

    200-500 WBC/UL

    Slightly Hazy

  • 39

    WBC, RBC. proteins, concentration, INCREASE lipid Microorganisms, Aspirated epidural , fats, rodiogrephic contrast media

    Turbid/ Milky

  • 40

    Meningitis, blockage of CSF circulation in subarachnoid

    Clotted

  • 41

    Clotted CSF DISEASE ASSOCIATED

    MENINGITIS, FROINS DISEASE

  • 42

    Bloody = Pathologic:

    INTRACRANIAL HEMORRHAGE (SUBARACHNOID HEMORRHAGE)

  • 43

    Bloody =NON Pathologic:

    TRAUMATIC TAP

  • 44

    Melastasizing mucin producing adenocarcinoma

    VISCOUS

  • 45

    VISCOUS ASSO. DISEASE

    CRYPTOCOCCAL MENINGITIS, ADENOCARCINOMA

  • 46

    Radiographic Conirast Media

    OILY

  • 47

    OILY CAUSES

    Radiographic Contrast Media

  • 48

    (Web-ike peliicle- overnight ref 12-24 hrs)

    Peliicle FORMATION

  • 49

    Peliicle FORMATION CAUSES

    TUBERCULAR MENINGITIS

  • 50

    Xanthocromia: COLOR--very slight amount of oxynemaoglobin

    PINK

  • 51

    Xanthocromia: COLOR Heavy HEMOLYSIS

    ORANGE

  • 52

    Xanthocromia: COLOR conversion of oxyhemoglobin to unconjugated bilirubin ! Other causes: 1 serum bilirubin, (+) carotene, tprotein (>150 mg/dl, melanoma pigment

    YELLOW

  • 53

    Brown

    Methemoglobin, hematoma, malanin

  • 54

    Methemoglobin, hematoma, malanin

    BROWN

  • 55

    Intracranial Hemorrhage Causes

    Haemorhage

  • 56

    Traumatic Tap Causes

    Puncture of blood vessel during procedure

  • 57

    Distribution of blood Intracranial Hemorrhage

    EVEN in all 3 tubes

  • 58

    Distribution of blood Traumatic Tap

    UNEVEN T1>T2>13/ Streaks of blood

  • 59

    Itracranial Hemorrhage Clot formation

    ABSENT

  • 60

    Traumatic Tap Clot formation

    PRESENT

  • 61

    Xanthocromic supernatant Intracranial Hemorrhage

    CLEAR

  • 62

    Xanthocromic supernatant Traumatic Tap

    PRESENT

  • 63

    Erythrophagocytosis Intracranial Hemorrhage

    PRESENT

  • 64

    Erythrophagocytosis Traumatic Tap

    ABSENT

  • 65

    D-dimer Test Intracranial Hemorrhage

    POSITIVE

  • 66

    D-dimer Test Traumatic Tap

    NEGATIVE

  • 67

    CHEMISTRY EXAMINATION OF CSF ntracranial Hemorrhage

    POSTIVE

  • 68

    CHEMISTRY EXAMINATION OF CSF Traumatic Tap

    NEGATIVE

  • 69

    CSF PROTEIN » NORMAL VALUES: Values are higher in infants and older persons

    15-45 MG/DL

  • 70

    MOST FREQUENTLY PERFORMED IN CHEMISTRY TEST

    CSF PROTEIN

  • 71

    (most abundant) => pre- -albumin (2%) ->a-globulins (haptoglobin, ceruplasmin] OR THE MAJOR CSF PROTEIN

    ALBUMIN

  • 72

    major B-globulin

    Transferrin

  • 73

    carbohydrate deficient fransferrin seen in CSF ONLY

    TAU

  • 74

    y-globulin:

    IgG>IgA

  • 75

    NOT FOUND IN NORMAL PLASMA CSF

    BETA LIPOPROTEIN, FIBRINOGEN, IGM

  • 76

    Increased CSF CAUSES

    Meningitis, Hemorrhage

  • 77

    Damage to BBB (INCREASED OR DECREASED)

    INCREASED

  • 78

    Decreased protein clearance from fluid (INCREASED OR DECREASED)

    INCREASED

  • 79

    Neural Tissue Degeneration (INCREASED OR DECREASED)

    INCREASED

  • 80

    Meningitis, Hemorrhage (INCREASED OR DECREASED)

    INCREASED

  • 81

    MS, Endocrine/ Metabolic disorders (INCREASED OR DECREASED)

    INCREASED

  • 82

    Leakage of fluid from the CNS (INCREASED OR DECREASED)

    DECREASED

  • 83

    Precipitates proteins using: TCA AND SSA

    Turbidimetric Method.

  • 84

    reagent of choice, precipitates albumin and globulin

    TRICHOLORO ACETIC ACID (TCA)

  • 85

    precipitates albumin, only unless combine with NA2SO4

    SULFOSALICYLIC ACID (SSA)

  • 86

    Protein-Error of indicator: LESS INTERFERENCE USES coomassie brilliant blue AND PYROGALLOL RED MOLYBDATE

    Dye-binding index

  • 87

    Dye-binding index THAT IS AUTOMATED

    PYROGALLOL RED MOLYBDATE

  • 88

    Dye-binding index THAT BINDS TO VARIETY OF PROTEINS

    coomassie brilliant blue

  • 89

    IT IS USE TO CHECK BBB

    PROTEIN FRACTIONS

  • 90

    USED TO MEASURE BBB INTEGRITY THROUGH CSF/ SERUM ALBUMIN INDEX

    CSF/ SERUM ALBUMIN

  • 91

    CSF/ SERUM ALBUMIN Index value of <9=_

    INTACT BBB

  • 92

    MS, stimulate immunocompetent cells in CNS, IgG synthesis in CNS

    CSF- IgG INDEX

  • 93

    CSF/ SERUM ALBUMIN Index value

    <9

  • 94

    Index value of CSF-IgG INDEX

    > 0.77

  • 95

    CSF/ SERUM ALBUMIN Index value of >0.77

    INDICES IgG PRODUCTION WITHIN CNS

  • 96

    (inflammation in the CNS) w/c is located in y region

    OLIGOCLONAL BANDS

  • 97

    Serum & CSF banding:

    Leukemia, Lymphoma, Viral infection (HIV)

  • 98

    CSF bonding (+); Serum banding (-); {IgG index :

    MULTIPLE SCLEROSIS

  • 99

    CSF bonding (+); Serum banding (-):

    MULSTIPLE SCLEROSIS, MENIGITIS, ENCEPHALITIS, NEUROSYPHILIS, GUILLAIN BARE

  • 100

    Method of Choice when determining a true CSF specimen:

    TAU IDENTIFICATION

  • other names parasitology

    other names parasitology

    Yves Laure Pimentel · 70問 · 2年前

    other names parasitology

    other names parasitology

    70問 • 2年前
    Yves Laure Pimentel

    PARASITOLOGY

    PARASITOLOGY

    Yves Laure Pimentel · 111問 · 2年前

    PARASITOLOGY

    PARASITOLOGY

    111問 • 2年前
    Yves Laure Pimentel

    HTMLBE

    HTMLBE

    Yves Laure Pimentel · 64問 · 2年前

    HTMLBE

    HTMLBE

    64問 • 2年前
    Yves Laure Pimentel

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    Yves Laure Pimentel · 61問 · 2年前

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    61問 • 2年前
    Yves Laure Pimentel

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    Yves Laure Pimentel · 69問 · 2年前

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    69問 • 2年前
    Yves Laure Pimentel

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    Yves Laure Pimentel · 100問 · 2年前

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    100問 • 2年前
    Yves Laure Pimentel

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    Yves Laure Pimentel · 41問 · 2年前

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    41問 • 2年前
    Yves Laure Pimentel

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    Yves Laure Pimentel · 87問 · 2年前

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    87問 • 2年前
    Yves Laure Pimentel

    CSF 2

    CSF 2

    Yves Laure Pimentel · 82問 · 2年前

    CSF 2

    CSF 2

    82問 • 2年前
    Yves Laure Pimentel

    SEMEN 1

    SEMEN 1

    Yves Laure Pimentel · 100問 · 2年前

    SEMEN 1

    SEMEN 1

    100問 • 2年前
    Yves Laure Pimentel

    SEMEN 2

    SEMEN 2

    Yves Laure Pimentel · 7問 · 2年前

    SEMEN 2

    SEMEN 2

    7問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    Yves Laure Pimentel · 100問 · 2年前

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    100問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    Yves Laure Pimentel · 6問 · 2年前

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    6問 • 2年前
    Yves Laure Pimentel

    SEROUS FLUID

    SEROUS FLUID

    Yves Laure Pimentel · 25問 · 2年前

    SEROUS FLUID

    SEROUS FLUID

    25問 • 2年前
    Yves Laure Pimentel

    PLEURAL FLUID

    PLEURAL FLUID

    Yves Laure Pimentel · 44問 · 2年前

    PLEURAL FLUID

    PLEURAL FLUID

    44問 • 2年前
    Yves Laure Pimentel

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    Yves Laure Pimentel · 18問 · 2年前

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    18問 • 2年前
    Yves Laure Pimentel

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    Yves Laure Pimentel · 30問 · 2年前

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    30問 • 2年前
    Yves Laure Pimentel

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    Yves Laure Pimentel · 92問 · 2年前

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    92問 • 2年前
    Yves Laure Pimentel

    FECALYSIS

    FECALYSIS

    Yves Laure Pimentel · 80問 · 2年前

    FECALYSIS

    FECALYSIS

    80問 • 2年前
    Yves Laure Pimentel

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    Yves Laure Pimentel · 89問 · 2年前

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    89問 • 2年前
    Yves Laure Pimentel

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    Yves Laure Pimentel · 86問 · 2年前

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    86問 • 2年前
    Yves Laure Pimentel

    MTLBE..

    MTLBE..

    Yves Laure Pimentel · 35問 · 2年前

    MTLBE..

    MTLBE..

    35問 • 2年前
    Yves Laure Pimentel

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    Yves Laure Pimentel · 19問 · 1年前

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    19問 • 1年前
    Yves Laure Pimentel

    CC-OSMOMETRY

    CC-OSMOMETRY

    Yves Laure Pimentel · 14問 · 1年前

    CC-OSMOMETRY

    CC-OSMOMETRY

    14問 • 1年前
    Yves Laure Pimentel

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    Yves Laure Pimentel · 43問 · 1年前

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    43問 • 1年前
    Yves Laure Pimentel

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    Yves Laure Pimentel · 49問 · 2年前

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    49問 • 2年前
    Yves Laure Pimentel

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    Yves Laure Pimentel · 97問 · 2年前

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    97問 • 2年前
    Yves Laure Pimentel

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    Yves Laure Pimentel · 57問 · 2年前

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    57問 • 2年前
    Yves Laure Pimentel

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    Yves Laure Pimentel · 63問 · 2年前

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    63問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 37問 · 2年前

    PROTEINS

    PROTEINS

    37問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    Yves Laure Pimentel · 91問 · 2年前

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    91問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    Yves Laure Pimentel · 98問 · 2年前

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    98問 • 2年前
    Yves Laure Pimentel

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    Yves Laure Pimentel · 61問 · 2年前

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    61問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 1

    Liver Function Test 1

    Yves Laure Pimentel · 100問 · 2年前

    Liver Function Test 1

    Liver Function Test 1

    100問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 2

    Liver Function Test 2

    Yves Laure Pimentel · 96問 · 2年前

    Liver Function Test 2

    Liver Function Test 2

    96問 • 2年前
    Yves Laure Pimentel

    TUMOR MARKERS

    TUMOR MARKERS

    Yves Laure Pimentel · 33問 · 2年前

    TUMOR MARKERS

    TUMOR MARKERS

    33問 • 2年前
    Yves Laure Pimentel

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    Yves Laure Pimentel · 41問 · 2年前

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    41問 • 2年前
    Yves Laure Pimentel

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    Yves Laure Pimentel · 17問 · 2年前

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    17問 • 2年前
    Yves Laure Pimentel

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    Yves Laure Pimentel · 14問 · 2年前

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    14問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 71問 · 2年前

    PROTEINS

    PROTEINS

    71問 • 2年前
    Yves Laure Pimentel

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    Yves Laure Pimentel · 7問 · 2年前

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    7問 • 2年前
    Yves Laure Pimentel

    ELECTROLYTES

    ELECTROLYTES

    Yves Laure Pimentel · 10問 · 2年前

    ELECTROLYTES

    ELECTROLYTES

    10問 • 2年前
    Yves Laure Pimentel

    DRUGS

    DRUGS

    Yves Laure Pimentel · 27問 · 2年前

    DRUGS

    DRUGS

    27問 • 2年前
    Yves Laure Pimentel

    TOXIC AGENTS:

    TOXIC AGENTS:

    Yves Laure Pimentel · 12問 · 2年前

    TOXIC AGENTS:

    TOXIC AGENTS:

    12問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    Yves Laure Pimentel · 100問 · 2年前

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    100問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    Yves Laure Pimentel · 29問 · 2年前

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    29問 • 2年前
    Yves Laure Pimentel

    hema diseases

    hema diseases

    Yves Laure Pimentel · 25問 · 2年前

    hema diseases

    hema diseases

    25問 • 2年前
    Yves Laure Pimentel

    AML

    AML

    Yves Laure Pimentel · 43問 · 2年前

    AML

    AML

    43問 • 2年前
    Yves Laure Pimentel

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    Yves Laure Pimentel · 71問 · 2年前

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    71問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    Yves Laure Pimentel · 31問 · 2年前

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    31問 • 2年前
    Yves Laure Pimentel

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    Yves Laure Pimentel · 34問 · 2年前

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    34問 • 2年前
    Yves Laure Pimentel

    PLATELET DISORDERS

    PLATELET DISORDERS

    Yves Laure Pimentel · 37問 · 2年前

    PLATELET DISORDERS

    PLATELET DISORDERS

    37問 • 2年前
    Yves Laure Pimentel

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    Yves Laure Pimentel · 100問 · 2年前

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    100問 • 2年前
    Yves Laure Pimentel

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    Yves Laure Pimentel · 12問 · 2年前

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    12問 • 2年前
    Yves Laure Pimentel

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    Yves Laure Pimentel · 39問 · 2年前

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    39問 • 2年前
    Yves Laure Pimentel

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    Yves Laure Pimentel · 55問 · 2年前

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    55問 • 2年前
    Yves Laure Pimentel

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    Yves Laure Pimentel · 37問 · 2年前

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    37問 • 2年前
    Yves Laure Pimentel

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    Yves Laure Pimentel · 44問 · 2年前

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    44問 • 2年前
    Yves Laure Pimentel

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    Yves Laure Pimentel · 50問 · 2年前

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    50問 • 2年前
    Yves Laure Pimentel

    1. HISTORY

    1. HISTORY

    Yves Laure Pimentel · 69問 · 2年前

    1. HISTORY

    1. HISTORY

    69問 • 2年前
    Yves Laure Pimentel

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    Yves Laure Pimentel · 38問 · 2年前

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    38問 • 2年前
    Yves Laure Pimentel

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    Yves Laure Pimentel · 21問 · 2年前

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    21問 • 2年前
    Yves Laure Pimentel

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    Yves Laure Pimentel · 15問 · 2年前

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    15問 • 2年前
    Yves Laure Pimentel

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    Yves Laure Pimentel · 32問 · 2年前

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    32問 • 2年前
    Yves Laure Pimentel

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    Yves Laure Pimentel · 30問 · 2年前

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    30問 • 2年前
    Yves Laure Pimentel

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    Yves Laure Pimentel · 38問 · 2年前

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    38問 • 2年前
    Yves Laure Pimentel

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    Yves Laure Pimentel · 48問 · 2年前

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    48問 • 2年前
    Yves Laure Pimentel

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    Yves Laure Pimentel · 35問 · 2年前

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    35問 • 2年前
    Yves Laure Pimentel

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 18問 · 2年前

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    18問 • 2年前
    Yves Laure Pimentel

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    Yves Laure Pimentel · 44問 · 2年前

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    44問 • 2年前
    Yves Laure Pimentel

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 23問 · 2年前

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    23問 • 2年前
    Yves Laure Pimentel

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    Yves Laure Pimentel · 34問 · 2年前

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    34問 • 2年前
    Yves Laure Pimentel

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    Yves Laure Pimentel · 12問 · 2年前

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    12問 • 2年前
    Yves Laure Pimentel

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    Yves Laure Pimentel · 16問 · 2年前

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    16問 • 2年前
    Yves Laure Pimentel

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    Yves Laure Pimentel · 15問 · 2年前

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    15問 • 2年前
    Yves Laure Pimentel

    12. ANTIBODY

    12. ANTIBODY

    Yves Laure Pimentel · 79問 · 2年前

    12. ANTIBODY

    12. ANTIBODY

    79問 • 2年前
    Yves Laure Pimentel

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    Yves Laure Pimentel · 97問 · 2年前

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    97問 • 2年前
    Yves Laure Pimentel

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    Yves Laure Pimentel · 11問 · 2年前

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    11問 • 2年前
    Yves Laure Pimentel

    1. INTERLEUKINS

    1. INTERLEUKINS

    Yves Laure Pimentel · 23問 · 2年前

    1. INTERLEUKINS

    1. INTERLEUKINS

    23問 • 2年前
    Yves Laure Pimentel

    2. INTERFERONS

    2. INTERFERONS

    Yves Laure Pimentel · 28問 · 2年前

    2. INTERFERONS

    2. INTERFERONS

    28問 • 2年前
    Yves Laure Pimentel

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    Yves Laure Pimentel · 8問 · 2年前

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    8問 • 2年前
    Yves Laure Pimentel

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 19問 · 2年前

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    19問 • 2年前
    Yves Laure Pimentel

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 76問 · 2年前

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    76問 • 2年前
    Yves Laure Pimentel

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    Yves Laure Pimentel · 21問 · 2年前

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    21問 • 2年前
    Yves Laure Pimentel

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    Yves Laure Pimentel · 29問 · 2年前

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    29問 • 2年前
    Yves Laure Pimentel

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    Yves Laure Pimentel · 19問 · 2年前

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    19問 • 2年前
    Yves Laure Pimentel

    19. CYTOKINES

    19. CYTOKINES

    Yves Laure Pimentel · 22問 · 2年前

    19. CYTOKINES

    19. CYTOKINES

    22問 • 2年前
    Yves Laure Pimentel

    20. INTERLEUKINS

    20. INTERLEUKINS

    Yves Laure Pimentel · 24問 · 2年前

    20. INTERLEUKINS

    20. INTERLEUKINS

    24問 • 2年前
    Yves Laure Pimentel

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    Yves Laure Pimentel · 21問 · 2年前

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21問 • 2年前
    Yves Laure Pimentel

    1. SERO

    1. SERO

    Yves Laure Pimentel · 54問 · 2年前

    1. SERO

    1. SERO

    54問 • 2年前
    Yves Laure Pimentel

    2. PRECIPITATION

    2. PRECIPITATION

    Yves Laure Pimentel · 38問 · 2年前

    2. PRECIPITATION

    2. PRECIPITATION

    38問 • 2年前
    Yves Laure Pimentel

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    Yves Laure Pimentel · 17問 · 2年前

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    17問 • 2年前
    Yves Laure Pimentel

    4. OUCHTERLONY

    4. OUCHTERLONY

    Yves Laure Pimentel · 15問 · 2年前

    4. OUCHTERLONY

    4. OUCHTERLONY

    15問 • 2年前
    Yves Laure Pimentel

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    Yves Laure Pimentel · 9問 · 2年前

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    9問 • 2年前
    Yves Laure Pimentel

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    Yves Laure Pimentel · 11問 · 2年前

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    11問 • 2年前
    Yves Laure Pimentel

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    Yves Laure Pimentel · 29問 · 2年前

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    29問 • 2年前
    Yves Laure Pimentel

    問題一覧

  • 1

    produce a mechanical barrier to cushion the cushion the brain and spinal cord against trauma trauma * Supply nutrients to the nervous tissue * Remove metabolic waste

    CEREBROSPINAL FLUID (CSF)

  • 2

    not an ultrafiltrate of plasma

    CEREBROSPINAL FLUID (CSF)

  • 3

    Brain & spinal cord are lined by

    Meninges

  • 4

    3 parts of meninges

    1. DURA MATER, 2. ARACHNOID MATER, 3.PIA MATER

  • 5

    outer layer; lines the skull & vertebral canal

    DURA MATER

  • 6

    Spider web-like/ filamentous inner membrane

    ARACHNOID

  • 7

    Thin membrane lining the surfaces of brain & spinal cord

    PIA MATER

  • 8

    PRODUCTION OF CSF

    Produced in CHOROID PLEXUS of lumbar ventricles & third & fourth ventricles

  • 9

    Flows through _________(Between arachnoid & pia mater)

    SUBARACHNOID

  • 10

    Reabsorbed by the _______________into the superior sagittal sinus

    ARACHNOID VILLI/ GRANULATION

  • 11

    CSF VOLUME:

    20 ML/PER HOUR

  • 12

    Adults: CSF VOLUME

    40-170 ML/ 90-150 ML

  • 13

    CSF VOLUME Neonates:

    10-60 mL

  • 14

    Endothelial cells have ________to prevent passage of molecules: How many Daltons?

    BLOOD BRAIN BARRIER (BBB): >500 daltons

  • 15

    used to represent the control and filtration of blood components to the CSF and then to the brain

    BLOOD BRAIN BARRIER (BBB)

  • 16

    Increased WBC, proteins, and coagulation factors in CSF

    Meningitis, Multiple Sclerosis

  • 17

    Routine method for CSF collection

    LUMBAR PUNCTURE

  • 18

    Between _____ Lumbar Vertebrae:

    3RD, 4TH, 5TH

  • 19

    Lumbar Vertebrae: ADULTS

    3RD AND 4TH

  • 20

    Lumbar Vertebrae: CHILDREN

    4TH AND 5TH

  • 21

    Patientis position in lumbar puncture

    FETAL POSITION OR LATERAL DECUBITUS POSITION

  • 22

    infants w/ open fontanels

    VENTICULAR PUNCTURE

  • 23

    collected in sub-occipital region

    CISTERIAL PUNCTURE

  • 24

    "Least affected by blood bacteria as a result of the tap procedure

    TUBE 1 CHEMISTRY AND SEROLOGY

  • 25

    TUBE 2 AND PRESERVATIVE

    MICROBIOLOGY, ROOM TEMPERATURE

  • 26

    Least likely fo contain C cells introduced by the tap procedure

    HEMATOLOGY/ CELL COUNT, REF TEMPERATURE; TUBE 3

  • 27

    LAST TUBE

    MICROBIOLOGY

  • 28

    Tests are performed on a ? WITHIN?

    STAT basis: 30 MINS

  • 29

    Supernatant fluid that is left over in every section:

    CHEMISTRY/ SEROLOGY

  • 30

    IF ONLY 1 TUBE: ORDER OF COLLECTION

    MICROBIOLOGY-> HEMATOLOGY-> CHEMISTRY/SEROLOGY

  • 31

    PHYSICAL EXAMINATION OR APPEARANCE OF CSF: ¥ Color:

    COLORLESS

  • 32

    PHYSICAL EXAMINATION OR APPEARANCE OF CSF: Viscosity:

    Same w/ water

  • 33

    PHYSICAL EXAMINATION OR APPEARANCE OF CSF: CLARITY

    Crystal Clear

  • 34

    PHYSICAL EXAMINATION OR APPEARANCE OF CSF: SPECIFIC GRAVITY

    1.006-1.008

  • 35

    PHYSICAL EXAMINATION OR APPEARANCE OF CSF: pH:

    7.30-7.45

  • 36

    PHYSICAL EXAMINATION OR APPEARANCE OF CSF: Pressure:

    50-200 mmH2

  • 37

    Slightly Hazy

    200-500 WBC/UL

  • 38

    200-500 WBC/UL

    Slightly Hazy

  • 39

    WBC, RBC. proteins, concentration, INCREASE lipid Microorganisms, Aspirated epidural , fats, rodiogrephic contrast media

    Turbid/ Milky

  • 40

    Meningitis, blockage of CSF circulation in subarachnoid

    Clotted

  • 41

    Clotted CSF DISEASE ASSOCIATED

    MENINGITIS, FROINS DISEASE

  • 42

    Bloody = Pathologic:

    INTRACRANIAL HEMORRHAGE (SUBARACHNOID HEMORRHAGE)

  • 43

    Bloody =NON Pathologic:

    TRAUMATIC TAP

  • 44

    Melastasizing mucin producing adenocarcinoma

    VISCOUS

  • 45

    VISCOUS ASSO. DISEASE

    CRYPTOCOCCAL MENINGITIS, ADENOCARCINOMA

  • 46

    Radiographic Conirast Media

    OILY

  • 47

    OILY CAUSES

    Radiographic Contrast Media

  • 48

    (Web-ike peliicle- overnight ref 12-24 hrs)

    Peliicle FORMATION

  • 49

    Peliicle FORMATION CAUSES

    TUBERCULAR MENINGITIS

  • 50

    Xanthocromia: COLOR--very slight amount of oxynemaoglobin

    PINK

  • 51

    Xanthocromia: COLOR Heavy HEMOLYSIS

    ORANGE

  • 52

    Xanthocromia: COLOR conversion of oxyhemoglobin to unconjugated bilirubin ! Other causes: 1 serum bilirubin, (+) carotene, tprotein (>150 mg/dl, melanoma pigment

    YELLOW

  • 53

    Brown

    Methemoglobin, hematoma, malanin

  • 54

    Methemoglobin, hematoma, malanin

    BROWN

  • 55

    Intracranial Hemorrhage Causes

    Haemorhage

  • 56

    Traumatic Tap Causes

    Puncture of blood vessel during procedure

  • 57

    Distribution of blood Intracranial Hemorrhage

    EVEN in all 3 tubes

  • 58

    Distribution of blood Traumatic Tap

    UNEVEN T1>T2>13/ Streaks of blood

  • 59

    Itracranial Hemorrhage Clot formation

    ABSENT

  • 60

    Traumatic Tap Clot formation

    PRESENT

  • 61

    Xanthocromic supernatant Intracranial Hemorrhage

    CLEAR

  • 62

    Xanthocromic supernatant Traumatic Tap

    PRESENT

  • 63

    Erythrophagocytosis Intracranial Hemorrhage

    PRESENT

  • 64

    Erythrophagocytosis Traumatic Tap

    ABSENT

  • 65

    D-dimer Test Intracranial Hemorrhage

    POSITIVE

  • 66

    D-dimer Test Traumatic Tap

    NEGATIVE

  • 67

    CHEMISTRY EXAMINATION OF CSF ntracranial Hemorrhage

    POSTIVE

  • 68

    CHEMISTRY EXAMINATION OF CSF Traumatic Tap

    NEGATIVE

  • 69

    CSF PROTEIN » NORMAL VALUES: Values are higher in infants and older persons

    15-45 MG/DL

  • 70

    MOST FREQUENTLY PERFORMED IN CHEMISTRY TEST

    CSF PROTEIN

  • 71

    (most abundant) => pre- -albumin (2%) ->a-globulins (haptoglobin, ceruplasmin] OR THE MAJOR CSF PROTEIN

    ALBUMIN

  • 72

    major B-globulin

    Transferrin

  • 73

    carbohydrate deficient fransferrin seen in CSF ONLY

    TAU

  • 74

    y-globulin:

    IgG>IgA

  • 75

    NOT FOUND IN NORMAL PLASMA CSF

    BETA LIPOPROTEIN, FIBRINOGEN, IGM

  • 76

    Increased CSF CAUSES

    Meningitis, Hemorrhage

  • 77

    Damage to BBB (INCREASED OR DECREASED)

    INCREASED

  • 78

    Decreased protein clearance from fluid (INCREASED OR DECREASED)

    INCREASED

  • 79

    Neural Tissue Degeneration (INCREASED OR DECREASED)

    INCREASED

  • 80

    Meningitis, Hemorrhage (INCREASED OR DECREASED)

    INCREASED

  • 81

    MS, Endocrine/ Metabolic disorders (INCREASED OR DECREASED)

    INCREASED

  • 82

    Leakage of fluid from the CNS (INCREASED OR DECREASED)

    DECREASED

  • 83

    Precipitates proteins using: TCA AND SSA

    Turbidimetric Method.

  • 84

    reagent of choice, precipitates albumin and globulin

    TRICHOLORO ACETIC ACID (TCA)

  • 85

    precipitates albumin, only unless combine with NA2SO4

    SULFOSALICYLIC ACID (SSA)

  • 86

    Protein-Error of indicator: LESS INTERFERENCE USES coomassie brilliant blue AND PYROGALLOL RED MOLYBDATE

    Dye-binding index

  • 87

    Dye-binding index THAT IS AUTOMATED

    PYROGALLOL RED MOLYBDATE

  • 88

    Dye-binding index THAT BINDS TO VARIETY OF PROTEINS

    coomassie brilliant blue

  • 89

    IT IS USE TO CHECK BBB

    PROTEIN FRACTIONS

  • 90

    USED TO MEASURE BBB INTEGRITY THROUGH CSF/ SERUM ALBUMIN INDEX

    CSF/ SERUM ALBUMIN

  • 91

    CSF/ SERUM ALBUMIN Index value of <9=_

    INTACT BBB

  • 92

    MS, stimulate immunocompetent cells in CNS, IgG synthesis in CNS

    CSF- IgG INDEX

  • 93

    CSF/ SERUM ALBUMIN Index value

    <9

  • 94

    Index value of CSF-IgG INDEX

    > 0.77

  • 95

    CSF/ SERUM ALBUMIN Index value of >0.77

    INDICES IgG PRODUCTION WITHIN CNS

  • 96

    (inflammation in the CNS) w/c is located in y region

    OLIGOCLONAL BANDS

  • 97

    Serum & CSF banding:

    Leukemia, Lymphoma, Viral infection (HIV)

  • 98

    CSF bonding (+); Serum banding (-); {IgG index :

    MULTIPLE SCLEROSIS

  • 99

    CSF bonding (+); Serum banding (-):

    MULSTIPLE SCLEROSIS, MENIGITIS, ENCEPHALITIS, NEUROSYPHILIS, GUILLAIN BARE

  • 100

    Method of Choice when determining a true CSF specimen:

    TAU IDENTIFICATION